Cost-effectiveness of early treatment for retinopathy of prematurity

Pediatrics

Volumn 123, Issue 1, 2009, Pages 262-269

  Kamholz, Karen L ^a,b   H Cole, Cynthia ^a   JamesEGray, ^c,d   F Zupancic, John A ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Costs and cost analysis; Infant; Newborn; Retinopathy of prematurity

Indexed keywords

ALLOPATHY; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; INFANT; LIFESPAN; LOW LEVEL LASER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PUBLISHING; RETROLENTAL FIBROPLASIA; SENSITIVITY ANALYSIS; STOCHASTIC MODEL; TREATMENT OUTCOME; VISUAL IMPAIRMENT; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; METHODOLOGY; MULTICENTER STUDY; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TIME;

COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MODELS, ECONOMIC; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOPATHY OF PREMATURITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 59449088656     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2725     Document Type: Article

References (16)

1. Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005; 116(1):15-23
2. Wheatley CM, Dickinson JL, Mackey DA, Craig JE, Sale MM. Retinopathy of prematurity: recent advances in our understanding. Arch Dis Child Fetal Neonatal Ed. 2002;87(2): F78-F82
3. Tasman W, Brown GC, Naidoff M, et al. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106(4):471-479
4. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthal-mol. 1990;108(10):1408-1416
5. Palmer EA, Hardy RJ, Dobson V, et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 2005;123(3):311-318
6. Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233-248
7. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Opthalmol. 2003;121(12): 1684-1694
8. McBride J, Parad R, Davis J, Allred L, Zupancic J. Cost analysis on the use of recombinant human superoxide dismutase (rhSOD) at birth in preterm infants to improve pulmonary outcome. J Perinatol. In press
9. Consumer Price Index (Medical Care, All Urban Consumers, Northeast Urban). National Bureau of Labor Statistics; 2006. Available at: www.bls.gov/cpi. Accessed March 1, 2007
10. Centers for Disease Control and Prevention. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment: United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57-59
11. Sharma S, Brown GC, Brown MM, et al. Converting visual acuity to utilities. Can J Ophthalmol. 2000;35(5):267-272
12. Arias E. United States life tables, 2001. Natl Vital Stat Rep. 2004;52(14):1-38
13. Javitt J, Dei Cas R, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics. 1993;91(5):859-866
14. Petrou S, Bischof M, Bennett C, Elbourne D, Field D, Mc-Nally H. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics. 2006;117(5): 1640 - 1649.
15. Lorch SA, Cnaan A, Barnhart K. Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics. 2004;114(2):417-426.
16. Keren R, Helfand M, Homer C, McPhillips H, Lieu TA. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics. 2002;110(5):855-864